Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity

Ophir Shani(Tel Aviv University), Neta Erez(Tel Aviv University)
Cancer Research
October 6, 2020
Cited by 150


Related Papers